All Stories

  1. Effects of CYP2D6 and CYP3A5 polymorphisms on tamoxifen and its metabolites in Thai breast cancer patients
  2. CYP2D6 and CYP3A5 polymorphisms in Thai breast cancer patients
  3. Effects of SULT1A1 Copy Number Variation on Estrogen Concentration and Tamoxifen-Associated Adverse Drug Reactions in Premenopausal Thai Breast Cancer Patients: A Preliminary Study
  4. Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation
  5. Breast Cancer Patients’ Perception On Health Impacts From Receiving Chemotherapy
  6. Prevalence of Febrile Neutropenia in Breast Cancer Patients Received Adjuvant Paclitaxel Treatment
  7. Change in Percentage of Left Ventricular Ejection Fraction in Breast Cancer Patients Received Trastuzumab Treatment
  8. Effects of CYP2D6 and UGT2B7 polymorphisms on pharmacokinetics of tamoxifen in Thai breast cancer patients
  9. PRM8 Could Corporate Social Responsibility Predict Pharmaceutical Corporate Financial performance?
  10. PCV16 COMPARATIVE EFFICACY OF LOSARTAN AND IRBESARTAN IN HYPERTENSIVE PATIENTS AT SARABURI HOSPITAL, THAILAND 2007